CLASS II Drug recall · Reported 29 Apr 2015 · FDA Enforcement Report

Droperidol injection, 2.5 mg/mL recalled by SCA Pharmaceuticals

SCA Pharmaceuticals is recalling Droperidol injection, 2.5 mg/mL, 5 mg Total Dose Fill Volume per syringe, distributed in Arkansas, Indiana, Minnesota, Missouri. The recall was initiated on 24 Feb 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 20141223@20
Quantity recalled421 syringes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0965-2015
FDA event ID
70583
Recalling firm
SCA Pharmaceuticals, Little Rock, AR
Classification
Class II
Status
Terminated
Recall initiated
24 Feb 2015
FDA classified
22 Apr 2015
Reported
29 Apr 2015
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

24 Feb 2015Recall initiated by company
22 Apr 2015Classified by FDA+57 days
29 Apr 2015Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of particulate.

Product as listed by the FDA

Droperidol injection, 2.5 mg/mL, 5 mg Total Dose, 2 mL Fill Volume per syringe, packaged in 10-count syringes per heat sealed bag, RX only; Compounded for Office Use by SCA Pharmaceuticals, Little Rock, AR (877 ) 550-5059 Bar Code 88888-7720-16

Where it was distributed

IN, AR, MO, MN

ArkansasIndianaMinnesotaMissouri

Questions about this recall

Why was it recalled?

Presence of particulate.

Which lots are affected?

Lot: 20141223@20

Where was it sold?

IN, AR, MO, MN

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from SCA Pharmaceuticals

All 166

Other Droperidol recalls

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDroperidol Injectable Sterile Solution, 0.625mg/mL recalledPremier Pharmacy LabsSterilityNationwide